CORD-19:85d7f47649ef43ff11b8d5196c98e4fdacd0f905 / 0-208
Annnotations
CORD-PICO
{"project":"CORD-PICO","denotations":[{"id":"p2_i0","span":{"begin":0,"end":31},"obj":"Pharmacological"},{"id":"p2_i1","span":{"begin":125,"end":151},"obj":"Pharmacological"}],"text":"Angiotensin-converting enzyme 2 in lung diseases This review comes from a themed issue on Respiratory pharmacology Edited by Dale Hoyt and Daren Knoell as novel therapeutic agents to treat severe acute lung f"}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T1","span":{"begin":35,"end":48},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002088"}],"text":"Angiotensin-converting enzyme 2 in lung diseases This review comes from a themed issue on Respiratory pharmacology Edited by Dale Hoyt and Daren Knoell as novel therapeutic agents to treat severe acute lung f"}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1","span":{"begin":35,"end":39},"obj":"Body_part"},{"id":"T2","span":{"begin":202,"end":206},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Angiotensin-converting enzyme 2 in lung diseases This review comes from a themed issue on Respiratory pharmacology Edited by Dale Hoyt and Daren Knoell as novel therapeutic agents to treat severe acute lung f"}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1","span":{"begin":35,"end":48},"obj":"Disease"},{"id":"T63040","span":{"begin":35,"end":48},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A99669","pred":"mondo_id","subj":"T63040","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"}],"text":"Angiotensin-converting enzyme 2 in lung diseases This review comes from a themed issue on Respiratory pharmacology Edited by Dale Hoyt and Daren Knoell as novel therapeutic agents to treat severe acute lung f"}